Kezar Life Sciences, Inc (KZR) - Biznesning o‘zini qoplash muddati

Kezar Life Sciences, Inc (KZR) brendining ramzi va logotipi

Kezar Life Sciences (KZR) biotexnologiyaga ESG tamoyillarini integratsiya qilgan holda, bioetika va chiqindilarni yo'q qilish standartlariga qat'iy rioya qiladi. Biznesning rivojlanishi R&D uchun barqaror naqd pul zaxirasi bilan qo'llab-quvvatlanadigan, tizimli qizil bo'ri (lupus) davolash bo'yicha klinik sinovlar natijalariga tayanadi. GURU.Markets platformasidagi ushbu narxlar grafigi P/E koeffitsiyenti -1.20 bo'lgan aktiv uchun bozor tendentsiyasini aks ettiradi, shu bilan birga, yetakchi immunologlar jamoasi akademik erkinlik sharoitida zamonaviy terapiyani ishlab chiqmoqda.

Narxning foydaga nisbati: Kezar Life Sciences, Inc. (KZR) 04.07.2022 - 23.05.2026 uchun

Kezar Life Sciences kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahlili:KZR (Kezar Life Sciences Inc.)
kezarlifesciences.com asosiy tovari

P/E koeffitsiyenti aktivning bozor qiymatini uning haqiqiy sof daromadiga nisbatan o'lchaydi, bu esa investorlarga spekulyativ shovqinlarni filtrlash va biznesning real qiymatini baholash imkonini beradi. Kapitalizatsiyasi tadqiqot va ishlanmalar (R&D) patent himoyasiga tayanadigan Kezar Life Sciences (KZR) uchun kompaniyaning taxminiy P/E koeffitsiyenti FDA testlari natijalari bo'yicha narxga kiritilgan kutishlar darajasini aks ettirib, joriy haddan ortiq baholanganlik va kelajakdagi o'sish potentsiali o'rtasidagi muvozanatni ko'rsatadi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics, Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Bio|Narxning foydaga nisbati Theratechnologies, Inc.|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics AVTX|P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|adagene.com (ADAG) - Narx-foyda koeffitsiyenti|Ikena Oncology (IMA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Shattuck Labs, Inc.|Narxning foydaga nisbati equilliumbio.com|Narx-foyda koeffitsiyenti connectbiopharm.com (CNTB)|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati Atara Bio|Narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Narxning foydaga nisbati|ACET: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CELU (celularity.com)|INMB: P/E multiplikatori|BRNS: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori